UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+5.87%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$4.01B
AUM Growth
+$484M
(+14%)
Cap. Flow
+$336M
Cap. Flow
% of AUM
8.39%
Top 10 Holdings %
Top 10 Hldgs %
56.46%
Holding
586
New
87
Increased
121
Reduced
176
Closed
112
Top Buys
| 1 |
Kellanova
K
|
$305M |
| 2 |
SRCL
Stericycle Inc
SRCL
|
$145M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
$104M |
| 4 |
CHX
ChampionX
CHX
|
$98.2M |
| 5 |
Spirit AeroSystems
SPR
|
$90.4M |
Top Sells
| 1 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$149M |
| 2 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$81.8M |
| 3 |
SWN
Southwestern Energy Company
SWN
|
$56.7M |
| 4 |
Union Pacific
UNP
|
$24.2M |
| 5 |
X
US Steel
X
|
$18.7M |
Sector Composition
| 1 | Energy | 21.14% |
| 2 | Technology | 19.82% |
| 3 | Healthcare | 14.53% |
| 4 | Industrials | 11.25% |
| 5 | Consumer Staples | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Edwards Lifesciences
EW
$47.5B
| $462K | 0.01% |
+7,000
| New | +$462K |
|
327
Corning
GLW
$61B
| $452K | 0.01% |
+10,000
| New | +$452K |
|
328
Ventyx Biosciences
VTYX
$180M
| $436K | 0.01% |
+200,000
| New | +$436K |
|
329
Leap Therapeutics
LPTX
$11.7M
| $424K | 0.01% |
165,108
+15,336
| +10% | +$39.4K |
|
330
Ardelyx
ARDX
$1.57B
| $418K | 0.01% |
60,736
-23,857
| -28% | -$164K |
|
331
CG Oncology
CGON
$2.52B
| $416K | 0.01% |
11,024
+1,024
| +10% | +$38.6K |
|
|
CRGX
332
DELISTED
CARGO Therapeutics
CRGX
| $407K | 0.01% |
22,048
+2,048
| +10% | +$37.8K |
|
333
Terns Pharmaceuticals
TERN
$632M
| $400K | 0.01% |
+48,000
| New | +$400K |
|
334
Black Diamond Therapeutics
BDTX
$167M
| $395K | 0.01% |
90,706
-213,000
| -70% | -$927K |
|
335
PayPal
PYPL
$65.2B
| $390K | 0.01% |
5,000
-5,000
| -50% | -$390K |
|
336
Mineralys Therapeutics
MLYS
$2.7B
| $376K | 0.01% |
31,068
-28,863
| -48% | -$350K |
|
337
Neurogene
NGNE
$285M
| $370K | 0.01% |
8,827
+1,727
| +24% | +$72.5K |
|
338
AMC Entertainment Holdings
AMC
$1.41B
| $350K | 0.01% |
77,028
-840
| -1% | -$3.82K |
|
|
MFA
339
MFA Financial
MFA
$1.07B
| $342K | 0.01% |
26,868
-70,553
| -72% | -$897K |
|
340
KraneShares CSI China Internet ETF
KWEB
$8.55B
| $340K | 0.01% |
+10,000
| New | +$340K |
|
341
Zura Bio
ZURA
$143M
| $329K | 0.01% |
80,912
+7,516
| +10% | +$30.5K |
|
342
Peloton Interactive
PTON
$3.27B
| $328K | 0.01% |
70,000
-190,000
| -73% | -$889K |
|
343
Asana
ASAN
$3.18B
| $290K | 0.01% |
25,000
-277,500
| -92% | -$3.22M |
|
344
Minerva Neurosciences
NERV
$16.4M
| $286K | 0.01% |
107,256
+7,400
| +7% | +$19.8K |
|
345
Alibaba
BABA
$323B
| $265K | 0.01% |
+2,500
| New | +$265K |
|
346
Texas Instruments
TXN
$171B
| $258K | 0.01% |
+1,250
| New | +$258K |
|
347
Veru
VERU
$49.4M
| $254K | 0.01% |
32,986
+3,064
| +10% | +$23.6K |
|
348
SCYNEXIS
SCYX
$37.3M
| $239K | 0.01% |
160,160
+14,877
| +10% | +$22.2K |
|
349
AbbVie
ABBV
$375B
| $226K | 0.01% |
1,146
-12,049
| -91% | -$2.38M |
|
350
Apellis Pharmaceuticals
APLS
$3.55B
| $219K | 0.01% |
+7,603
| New | +$219K |
|